Hisamitsu Pharmaceutical Co (TSE:4530) FFO per Share


TSE:4530 Hisamitsu Pharmaceutical Co Inc TSE:4530
69 GF Score
Price 円6,040.00
GF Value 円4,938.86
Valuation Modestly Overvalued
View Full Analysis

What is Hisamitsu Pharmaceutical Co FFO per Share?

FFO per Share only applies to REITs.

TSE:4530
69GF Score
Hisamitsu Pharmaceutical Co Inc TSE:4530
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hisamitsu Pharmaceutical Co (TSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円6,040.00 is trading 22.3% above its estimated GF Value™ of 円4,938.86. GuruFocus considers Hisamitsu Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4530:

  • FFO per Share:
  • GF Value™: 円4,938.86 vs. price of 円6,040.00 (22.3% above fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the TSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
69GF Score

Get the complete analysis for TSE:4530

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,040.00
Price
円4,938.86
GF Value